07 Dec 2024
// PRESS RELEASE
29 Nov 2024
// PRESS RELEASE
12 Nov 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About
Industry Trade Show
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
CONTACT DETAILS
FDFs
fpd.opr@egis.hu
APIs
bulk.opr@egis.hu
Services:
pharmaservices@egis.hu
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
CORPORATE CONTENT #SupplierSpotlight
07 Dec 2024
// PRESS RELEASE
https://int.egis.health/a/the-2024-hungarian-innovation-grand-prize-contest-was-announced-at-egis
29 Nov 2024
// PRESS RELEASE
https://int.egis.health/a/csaba-poroszlai-at-the-conference-on-the-competitiveness-of-the-european-and-hungarian-pharmaceutical-industry
12 Nov 2024
// PRESS RELEASE
https://int.egis.health/a/agreement-for-biosimilar-candidates-in-key-central-and-eastern-european-markets
19 Oct 2024
// PRESS RELEASE
https://int.egis.health/a/ten-years-together-egis-pharmaceuticals-plc-remains-the-partner-of-the-kormend-basketball-team
01 Oct 2024
// PRESS RELEASE
26 Mar 2024
// PRESS RELEASE
https://int.egis.health/a/egis-medicines-won-the-innovation-grand-prize
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17193
Submission : 2004-02-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-06-10
Pay. Date : 2021-06-07
DMF Number : 7882
Submission : 1989-01-24
Status : Active
Type : II
Certificate Numbers : R1-CEP 1996-032 - Rev 05
Status : Valid
Issue Date : 2019-08-09
Type : Chemical
Substance Number : 576
Certificate Numbers : CEP 2014-364 - Rev 01
Status : Valid
Issue Date : 2023-11-27
Type : Chemical
Substance Number : 576
Certificate Numbers : CEP 2023-411 - Rev 00
Status : Valid
Issue Date : 2024-06-14
Type : Chemical
Substance Number : 1491
Certificate Numbers : R1-CEP 2007-185 - Rev 02
Status : Valid
Issue Date : 2016-12-19
Type : Chemical
Substance Number : 1491
Certificate Numbers : R1-CEP 2014-252 - Rev 02
Status : Valid
Issue Date : 2022-07-21
Type : Chemical
Substance Number : 2617
Certificate Numbers : R0-CEP 2019-090 - Rev 00
Status : Valid
Issue Date : 2021-03-16
Type : Chemical
Substance Number : 1710
Certificate Numbers : R1-CEP 2003-042 - Rev 03
Status : Valid
Issue Date : 2019-02-20
Type : Chemical
Substance Number : 1745
Certificate Numbers : R1-CEP 2016-314 - Rev 00
Status : Valid
Issue Date : 2023-08-28
Type : Chemical
Substance Number : 1745
Certificate Numbers : R1-CEP 1996-077 - Rev 07
Status : Valid
Issue Date : 2021-10-15
Type : Chemical
Substance Number : 475
Certificate Numbers : R1-CEP 2004-053 - Rev 01
Status : Valid
Issue Date : 2019-04-16
Type : Chemical
Substance Number : 457
Details:
The formulation contains a eutectic mixture of 7% lidocaine and 7% tetracaine that utilizes phase-changing topical cream Peel technology. In clinical studies, the mean duration of anesthesia has been shown to be in the range of 7 to 9 hours after the application of Pliaglis.
Lead Product(s): Lidocaine,Tetracaine
Therapeutic Area: Neurology Brand Name: Pliaglis
Study Phase: ApprovedProduct Type: Small molecule
Recipient: Crescita Therapeutics
Deal Size: Undisclosed Upfront Cash: $0.7 million
Deal Type: Licensing Agreement December 13, 2021
Lead Product(s) : Lidocaine,Tetracaine
Therapeutic Area : Neurology
Highest Development Status : Approved
Recipient : Crescita Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
Details : The formulation contains a eutectic mixture of 7% lidocaine and 7% tetracaine that utilizes phase-changing topical cream Peel technology. In clinical studies, the mean duration of anesthesia has been shown to be in the range of 7 to 9 hours after the app...
Brand Name : Pliaglis
Molecule Type : Small molecule
Upfront Cash : $0.7 million
December 13, 2021
Details:
The active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI).
Lead Product(s): Favipiravir
Therapeutic Area: Infections and Infectious Diseases Brand Name: Favipiravir-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: National Institute of Pharmacy and Nutrition
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 20, 2020
Lead Product(s) : Favipiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : National Institute of Pharmacy and Nutrition
Deal Size : Not Applicable
Deal Type : Not Applicable
Egis Favipiravir Drug Licenced for Covid-19 Treatment
Details : The active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI).
Brand Name : Favipiravir-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 20, 2020
Services
API Manufacturing
Pharma Service : API Manufacturing
Category : Small Molecules
Sub Category : Overview
Pharma Service : API Manufacturing
API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Small Molecules
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Fine Chemical / Intermediate
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : High Potency APIs (HPAPIs)
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Clinical Supply
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : API Development
Sub Category : Scale-Up Capabilities
Pharma Service : API & Drug Product Development
Inspections and registrations
ABOUT THIS PAGE
Egis Pharmaceuticals PLC is a supplier offers 48 products (APIs, Excipients or Intermediates).
Find a price of Allopurinol bulk with CEP, JDMF offered by Egis Pharmaceuticals PLC
Find a price of Chlorpromazine Hydrochloride bulk with CEP, JDMF offered by Egis Pharmaceuticals PLC
Find a price of Ethacrynic Acid bulk with DMF, CEP offered by Egis Pharmaceuticals PLC
Find a price of Promethazine Hydrochloride bulk with DMF, CEP offered by Egis Pharmaceuticals PLC
Find a price of Allopurinol bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Amlodipine Besylate bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Aripiprazole bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Bisoprolol Fumarate bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Carbidopa bulk with JDMF offered by Egis Pharmaceuticals PLC
Find a price of Carvedilol bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Levomepromazine Maleate bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Methyldopa bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Nitrendipine bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Quetiapine Hemifumarate bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Ramipril bulk with CEP offered by Egis Pharmaceuticals PLC
Find a price of Tofisopam bulk with JDMF offered by Egis Pharmaceuticals PLC
Find a price of Abemaciclib bulk offered by Egis Pharmaceuticals PLC
Find a price of Abrocitinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Acalabrutinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Alectinib Hydrochloride bulk offered by Egis Pharmaceuticals PLC
Find a price of Avapritinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Blarcamesine bulk offered by Egis Pharmaceuticals PLC
Find a price of Clomiphene Citrate bulk offered by Egis Pharmaceuticals PLC
Find a price of Crotamiton bulk offered by Egis Pharmaceuticals PLC
Find a price of Dapagliflozin Propanediol Monohydrate bulk offered by Egis Pharmaceuticals PLC
Find a price of Deucravacitinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Donepezil bulk offered by Egis Pharmaceuticals PLC
Find a price of Duloxetine Hydrochloride bulk offered by Egis Pharmaceuticals PLC
Find a price of Empagliflozin bulk offered by Egis Pharmaceuticals PLC
Find a price of Entrectinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Etrasimod bulk offered by Egis Pharmaceuticals PLC
Find a price of Fruquintinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Ketoprofen bulk offered by Egis Pharmaceuticals PLC
Find a price of LCZ 696 bulk offered by Egis Pharmaceuticals PLC
Find a price of Levocetirizine Dihydrochloride bulk offered by Egis Pharmaceuticals PLC
Find a price of Nifedipine bulk offered by Egis Pharmaceuticals PLC
Find a price of Osimertinib Mesylate bulk offered by Egis Pharmaceuticals PLC
Find a price of Ozanimod Hydrochloride bulk offered by Egis Pharmaceuticals PLC
Find a price of Palbociclib bulk offered by Egis Pharmaceuticals PLC
Find a price of Pimavanserin Tartrate bulk offered by Egis Pharmaceuticals PLC
Find a price of Pregabalin bulk offered by Egis Pharmaceuticals PLC
Find a price of Resmetirom bulk offered by Egis Pharmaceuticals PLC
Find a price of Ribociclib bulk offered by Egis Pharmaceuticals PLC
Find a price of Rivaroxaban bulk offered by Egis Pharmaceuticals PLC
Find a price of Solriamfetol Hydrochloride bulk offered by Egis Pharmaceuticals PLC
Find a price of Troriluzole bulk offered by Egis Pharmaceuticals PLC
Find a price of Upadacitinib bulk offered by Egis Pharmaceuticals PLC
Find a price of Venetoclax bulk offered by Egis Pharmaceuticals PLC
LOOKING FOR A SUPPLIER?